Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Dry Eye Disease Treatment Market: By Product: Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Others; By Distribution Channel: Hospital Pharmacies, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Dry Eye Disease Treatment Market Outlook

The global dry eye disease treatment market attained a value of about USD 5 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 5.7% to reach nearly USD 7 billion by 2026.

 

Growing Geriatric Population Aiding the Market Growth of Dry Eye Disease Treatment

The rising awareness regarding the wide prevalence of dry eye diseases is aiding the market growth. The increasing geriatric population, especially in developed countries, is surging the cases of dry eye disease, which is propelling the market growth. As patients with underlying health-related issues such as lupus, diabetes, arthritis, and thyroid-associated diseases are more prone to eye-related complications, including dry eye disease, the surging cases of such health issues are augmenting the industry growth.

 

Global Dry Eye Disease Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The rising dependence on technologies for various essential applications, especially among the millennial and the Gen-Z population, is increasing the cases of dry eye disease owing to the strain caused due to prolonged screen exposure, which is further invigorating the industry growth.

The rising smartphone ownership among all socioeconomic classes is increasing the prevalence of dry eye complications, therefore, significantly contributing to the industry growth. This trend was elevated during the COVID-19 outbreak in 2020, which escalated the dependency on digital technology for working, shopping, and socialising as remote work conditions and stay-at-home orders prevailed. In addition, wearing masks for a long period of time to prevent the spread of the virus also led to a surge in dry eye conditions by forcing air over the eye surface, which provided further impetus to the market growth.

 

Dry Eye Disease Treatment: Industry Definition and Segmentation

Dry eye disease is an eye-related condition that is caused by the lack of lubrication and moisture on the surface of the eye. Tear instability, a prominent cause of dry eye, can lead to damage and inflammation of the surface of the eye. It is one of the most common eye-related issues and is prevalent in the geriatric population. The disease can be treated through artificial tears, anti-inflammatory drugs like cyclosporin and corticosteroid, punctal plugs, and secretogogues.

The major products of dry eye disease treatment are:

  • Artificial Tears
  • Anti-Inflammatory Drugs
    • Cyclosporine
    • Corticosteroid
    • Others
  • Punctal Plugs
  • Secretagogues
  • Others

The market can be broadly categorised on the basis of its distribution channels into:

  • Hospital Pharmacies
  • Independent Pharmacies and Drug Stores
  • Online Pharmacies

The EMR report looks into the regional markets of dry eye disease treatment like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Development of Innovative Treatments for Dry Eye Disease to Drive the Dry Eye Disease Treatment Industry

The market growth of dry eye disease treatment is being driven by the development of various innovative treatments. The increasing research and development (R&D) activities by the leading companies are leading to the development of drugs for temporary relief from the symptoms of dry eye for patients with critical conditions, which is expected to propel the market growth. Moreover, various clinical trials initiated are anticipated to further augment the growth of the dry eye disease treatment industry. As healthcare accessibility in low and middle-income countries is increasing robustly, the treatment for dry eye diseases is escalating, which is projected to positively impact the market growth. In addition, the increasing approval of novel drugs by various organisations such as the Food and Drug Organisation (FDA) in the United States is surging the availability of diverse treatments, which is projected to propel the market growth. The extensive development of various devices to stimulate tears is also projected to invigorate the industry growth in the forecast period.

 

Key Industry Players in the Global Dry Eye Disease Treatment Market

The report presents a detailed analysis of the following key players in the global dry eye disease treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc.
  • Bausch and Lomb Incorporated
  • Johnson & Johnson Services, Inc.
  • Santen Pharmaceutical Co., Ltd
  • OASIS Medical
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Distribution Channel, Region
Breakup by Product Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Others
Breakup by Distribution Channel Hospital Pharmacies, Independent Pharmacies and Drug Stores, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AbbVie Inc., Bausch and Lomb Incorporated, Johnson & Johnson Services, Inc., Santen Pharmaceutical Co., Ltd, OASIS Medical, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Dry Eye Disease Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Dry Eye Disease Treatment Historical Market (2016-2020) 
    8.3    Global Dry Eye Disease Treatment Market Forecast (2021-2026)
    8.4    Global Dry Eye Disease Treatment Market by Product
        8.4.1    Artificial Tears
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Anti-Inflammatory Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Cyclosporine
                8.4.2.4.2    Corticosteroid
                8.4.2.4.3    Others
        8.4.3    Punctal Plugs
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Secretagogues
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Others
    8.5    Global Dry Eye Disease Treatment Market by Distribution Channel
        8.5.1    Hospital Pharmacies
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Independent Pharmacies and Drug Stores
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Online Pharmacies
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
    8.6    Global Dry Eye Disease Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    AbbVie Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Bausch and Lomb Incorporated
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Johnson & Johnson Services, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Santen Pharmaceutical Co., Ltd
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    OASIS Medical
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Dry Eye Disease Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Dry Eye Disease Treatment Historical Market: Breakup by Product (USD Billion), 2016-2020
3.    Global Dry Eye Disease Treatment Market Forecast: Breakup by Product (USD Billion), 2021-2026
4.    Global Dry Eye Disease Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
5.    Global Dry Eye Disease Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
6.    Global Dry Eye Disease Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
7.    Global Dry Eye Disease Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
8.    North America Dry Eye Disease Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
9.    North America Dry Eye Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
10.    Europe Dry Eye Disease Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    Europe Dry Eye Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Asia Pacific Dry Eye Disease Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Asia Pacific Dry Eye Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Latin America Dry Eye Disease Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Latin America Dry Eye Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Middle East and Africa Dry Eye Disease Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Middle East and Africa Dry Eye Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Global Dry Eye Disease Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global dry eye disease treatment market attained a value of nearly USD 5 billion.

The market is projected to grow at a CAGR of 5.7% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 7 billion by 2026.

The market is being driven by the rising prevalence of eye complications among the geriatric population and the increasing eye strain caused by extensive screen exposure.

The market is expected to be driven by the increasing research and development (R&D) activities, the development of innovative drugs, and surging clinical trials.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of dry eye disease in the industry are artificial tears, anti-inflammatory drug, punctal plugs, and secretagogues, among others.

The significant distribution channels in the market are hospital pharmacies, independent pharmacies and drug stores, and online pharmacies.

The major players in the industry are AbbVie Inc., Bausch and Lomb Incorporated, Johnson & Johnson Services, Inc., Santen Pharmaceutical Co., Ltd, and OASIS Medical, among others.

Analyst Review

The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the increasing research and development (R&D) activities, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 5.7%. The market is projected to reach about USD 7 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the dry eye disease treatment industry can be segmented into artificial tears, anti-inflammatory drug, punctal plugs, and secretagogues, among others. On the basis of distribution channels, the industry is divided into hospital pharmacies, independent pharmacies and drug stores, and online pharmacies. The major regional markets for dry eye disease treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Bausch and Lomb Incorporated, Johnson & Johnson Services, Inc., Santen Pharmaceutical Co., Ltd, and OASIS Medical, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER